The newly-created position is reflective of the company’s plans for further global expansion and has international responsibility for all aspects of the commercial business. Ian holds a PhD in Pharmaceutical Science and with over 20 years’ experience in the pharmaceutical industry, his most recent role was at Catalent where he was responsible for the global provision of contract development and manufacturing services for oral dose forms.
